|

Self-Management Activities Benefit Mesothelioma Patients

Self-Management Interventions Benefits Mesothelioma Patients

Self-management activities are a proven way to fight fatigue and anxiety. They also improve poor sleep quality.

A recent report showed that self-management activities are improving lung cancer patient outcomes.

Results ask mesothelioma patients to use self-management activities. They are a proven way to improve a patient’s quality of life.

What are Self-Management Activities?

Self-management activities allow patients to manage their disease. These activities include managing symptoms, medications, physical activity, and dietary behaviors.

Results say grab a partner! Early-stage disease patients with a partner have the most benefit. Dr. Rachel Anne Rowntree from the University of Wollongong in Australia stated, “This review supports evidence that there are improved outcomes in cancer among those with a partner.”

The Studies and the Patients Included

The study canvased over 587 studies in their first search. They used 10 studies that looked at the benefits of self-management activities. The total patient pool was 1,089 patients.

The mean age was 61.86 years. This is almost one decade younger than the median age of lung cancer diagnosis.

Participant gender was evenly split. Female patients equated to 50.1% (n = 546). When taken together, studies showed that females had a larger benefit.

Most patient patients were either married or not living alone. No studies focused on the involvement of family caregivers in self-management activities.

Best Activities for the Best Results

There were four activity types. Exercise was the activity of choice in 60% of the studies. Two studies utilized self-management education. One study used a telephone-based symptom reporting tool. And the last study adopted a patient quality of life diary.

Fatigue, exercise capacity, and other various activities were included in the pooled analysis. One study demonstrated positive outcomes for anxiety/depression and sleep quality.

Home-based exercise is a cost-effective alternative to hospital-based programs. Hospital-based exercise has shown significant improvement in exercise capacity and quality of life. But it has not shown improvement for fatigue, depression, and anxiety.

The results of this study show that physical exercise brings improved patient outcomes. Exercise in early-stage lung cancer also has positive effects.

Self-Management Activities Work in Mesothelioma

Early-stage lung cancer is diagnosed in approximately 40% of patients. Treatment goals include a surgical and curative intent approach to a palliative approach.

Mesothelioma has a poor prognosis. The aim of treatment is often palliative care. Patients with mesothelioma often have several other issues which may impact function.

The benefits of self-management activities in mesothelioma patients are immense. Positive outcomes include decreased fatigue and anxiety/depression. There was an increase in sleep quality and quality of life.

Future research will focus on the benefits of family caregivers with mesothelioma patients.

Sources:

Rowntree, R. A., & Hosseinzadeh, H. (2022). Lung Cancer and Self-Management Interventions: A Systematic Review of Randomised Controlled Trials. International journal of environmental research and public health, 19(1), 536. https://www.mdpi.com/1660-4601/19/1/536

Similar Posts

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • | |

    Radiotherapy for Mesothelioma: Better But Still Limited

    A form of highly-targeted radiation therapy for mesothelioma is better than it used to be, but is still risky. That is the message of a recent article on intensity-modulated radiation therapy (IMRT) in Seminars in Thoracic and Cardiovascular Surgery. Author Kenneth E. Rosenzweig, MD, a Radiation Oncologist with Mount Sinai Hospital in New York, reviewed recent studies on IMRT and mesothelioma. He concludes that, while the “troubling toxicity” associated with IMRT when it was first introduced has not been entirely eliminated, the fact that clinicians now have more experience with it is making a positive difference for mesothelioma patients. Before targeted therapies like IMRT were available, high-dose radiation was not usually a feasible option for mesothelioma since the irregular shape…

  • | |

    A Second-Line Option for Mesothelioma?

    Although survival was not significantly extended, the chemotherapy drug vinorelbine might be a treatment option for mesothelioma patients whose cancer has returned after first-line chemotherapy with pemetrexed. A new study on vinorelbine as a second-line treatment finds that the drug is “moderately active” in mesothelioma patients who were initially treated with pemetrexed-based chemotherapy. Pemetrexed (Alimta), along with a platinum-based drug like cisplatin, is the primary first-line drug therapy for mesothelioma. But vinorelbine is gaining attention as a possible option for mesothelioma, in part because it is available in a less expensive generic form. In “Vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma”, the Italian authors detail the results of their study on 59 patients with unresectable pleural mesothelioma.  These patients…

  • | |

    Repeat HIPEC Improves Mesothelioma Survival

    If one cytoreductive surgery and HIPEC procedure for mesothelioma is good, subsequent treatments may be even better. That is the central message of research conducted at the Moffitt Cancer Center in Florida. The study’s aim was to assess overall survival among peritoneal mesothelioma patients who had not just one, but two or more rounds of heated intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery. The cytoreduction/HIPEC approach has become popular for peritoneal mesothelioma, a treatment-resistant cancer of abdominal membranes caused by asbestos. Cytoreductive surgery involves removing as much of the mesothelioma tumor as possible from the abdomen. Because the shape and spreading pattern of mesothelioma tumors make complete cytoreduction difficult, the surgery is often followed by a rinse with a heated solution…

  • | |

    Value of Mesothelioma Surgery Challenged for Healthy Patients

    New research conducted in Italy and presented at the 15th World Conference on Lung Cancer in Sydney, Australia suggests that mesothelioma surgery – no matter what kind – may not offer a survival advantage over medical management for the healthiest of patients. Mesothelioma is a rare but aggressive malignancy that is highly resistant to standard cancer treatments. The two types of mesothelioma surgery considered to be options for people with resectable cancer are pleurectomy decortication (P/D) or extrapleural pneumonectomy (EPP). While EPP is more radical than P/D because it involves removing a lung, both carry a heavy risk of complications and, according to the Italian researchers, may not be of value for certain patients. The study reviewed data from 1,365…